Hikma Pharmaceutical | HIK - Net Income

Stock Price
1,552.00
Daily Change
-80.00 -4.90%
Monthly
-2.08%
Yearly
-32.35%
Q1 Forecast
1,498.57

Hikma Pharmaceutical reported $119M in Net Income for its fiscal semester ending in June of 2025.





Net Income Change Date
Almirall EUR 26.58M 31.82M Jun/2025
argenx SE USD 344.26M 98.9M Sep/2025
AstraZeneca USD 2.53B 83M Sep/2025
Autolus Therapeutics Ltd USD -47.92M 22.24M Jun/2025
Bayer EUR -963M 764M Sep/2025
Fresenius EUR 344M 14M Sep/2025
Galapagos EUR -202.11M 96.36M Sep/2025
Genmab DKK 336M 141M Jun/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
GRIFOLS EUR 126.96M 9.9M Sep/2025
Hikma Pharmaceutical USD 119M 14M Jun/2025
Lonza CHF 307M 22M Dec/2024
Merck EUR 902M 250M Sep/2025
Orion EUR 96M 13.5M Sep/2025
Recordati EUR 110.16M 19.08M Sep/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
UCB EUR 857M 649M Dec/2024